These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10377739)

  • 1. [Clinico-pathology of lobular breast cancer].
    Langmár Z; Orosz Z
    Orv Hetil; 1999 May; 140(20):1099-102. PubMed ID: 10377739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second operation more frequent following breast-conserving treatment for invasive lobular than for invasive non-lobular carcinoma].
    de Zeeuw S; Wildenberg F; Strobbe L; Wobbes T
    Ned Tijdschr Geneeskd; 2009; 153():A56. PubMed ID: 19900317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lymph node positivity in multifocal and multicentric breast cancer.
    Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
    J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of early breast cancer in day surgery.
    Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
    Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node biopsy in elderly breast cancer patients.
    Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
    Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
    Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
    Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaplastic squamous cell carcinoma in association with invasive lobular breast carcinoma with metastasis to axillary lymph nodes.
    Khan MI; ul Haque A; Younas M; Zafar A; Shah H
    J Ayub Med Coll Abbottabad; 2011; 23(4):135-7. PubMed ID: 23472437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.